All
Search
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Top suggestions for Durvalumab Immunotherapy
Immunotherapy
Procedure
Durvalumab
by Imfinzi
Immunotherapy
Infusion
Immunotherapy
Animation
Durvalumab Immunotherapy
Lung Cancer
Immunotherapy
AG
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Immunotherapy
Procedure
Durvalumab
by Imfinzi
Immunotherapy
Infusion
Immunotherapy
Animation
Durvalumab Immunotherapy
Lung Cancer
Immunotherapy
AG
0:34
4.6K views · 205 reactions | The FDA has expanded its approval of...
4.7K views
2 weeks ago
Facebook
Moffitt Cancer Center
FDA Approval of Durvalumab for Advanced Bladder Cancer
Apr 22, 2017
onclive.com
Dr. Sonpavde on Fixed-Dose Durvalumab and Tremelimumab S
…
Feb 10, 2018
onclive.com
2:30
7.7K views · 52 reactions | In patients with muscle-invasive blad
…
1.7K views
2 weeks ago
Facebook
The New England Journal of Medicine
2:43
FDA Approves Durvalumab / Imfinzi for Resectable NSCLC Non-Small
…
3.3K views
Sep 12, 2024
YouTube
OncologyTube
3:07
The Use of Durvalumab in Locally Advanced NSCLC
261 views
Apr 16, 2018
YouTube
Targeted Oncology
6:29
Durvalumab ( Imfinzi ) for HCC
264 views
Aug 15, 2024
YouTube
PharmComm
4:25
Durvalumab Tolerability in Non–Small Cell Lung Cancer
1.3K views
Feb 25, 2020
YouTube
Targeted Oncology
1:39
Durvalumab mode of action
824 views
Jan 28, 2023
YouTube
Asif Biotech
2:03
Durvalumab FDA Approval for Bladder Cancer
198 views
May 5, 2017
YouTube
OncLive
7:44
Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of C
…
2.9K views
Feb 20, 2018
YouTube
BeaconMedIC
10:01
SCLC Immunotherapy: Durvalumab Breakthroughs & Biomarker Chall
…
1 views
2 months ago
YouTube
The Creative Flow
5:25
Durvalumab Plus BCG: A New Hope for High-Risk Non-Muscle Invasiv
…
2 views
2 months ago
YouTube
All Sides Now
Durvalumab: A Review in Extensive-Stage SCLC
Jan 27, 2020
nih.gov
0:08
GO2 for Lung Cancer on Instagram: "📢 The @fda has approved Imfinzi (
…
581 views
Dec 6, 2024
Instagram
go2forlungcancer
3:02
Durvalumab Plus BCG: A New Hope for High-Risk Bladder Cancer?
3 views
1 month ago
YouTube
Universal Moments
7:47
Durvalumab and BCG: A New Treatment Option for High-Risk Bl
…
1 views
2 months ago
YouTube
The Open Forum
8:28
Imfinzi Uses: Guide to Understanding the Many Benefits
…
1.4K views
Sep 11, 2023
YouTube
Inevid
52:55
Immunotherapy Nightmare - Imfinzi/Durvalumab Experience - L
…
400.5K views
Sep 18, 2022
YouTube
The Apples
1:06
The Mechanism of Action of Durvalumab in the Treatment of Ur
…
1.5K views
Aug 10, 2016
YouTube
Targeted Oncology
4:23
Imfinzi FDA Approval: New Immunotherapy for Early Gastric
…
2 months ago
YouTube
Worldwide Reflections
2:15
The impact of durvalumab for resectable non-small cell lung can
…
434 views
Sep 26, 2024
YouTube
VJOncology
1:17
The impact of durvalumab on the SCLC treatment landscape
298 views
9 months ago
YouTube
VJOncology
2:31
Perioperative Durvalumab in Bladder Cancer | NEJM
1.3K views
Nov 14, 2024
YouTube
NEJM Group
6:04
Durvalumab plus chemotherapy significantly improved OS in adva
…
1.4K views
Mar 21, 2022
YouTube
ecancer
0:59
Can you use Durvalumab with Lurbinectedin in Maintenance Par
…
631 views
4 months ago
YouTube
OncBrothers: Practice-Changing Cancer Discus…
1:08
Neoadjuvant Durvalumab Shows Benefit in Triple-Negative Breast C
…
420 views
Jan 2, 2020
YouTube
Targeted Oncology
2:34
Side Effects of Immunotherapy: What to Know
5 months ago
cancerresearch.org
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carci
…
213 views
Jun 6, 2022
nejm.org
2:25
Imfinzi (durvalumab) plus bevacizumab met endpoints in EM
…
223 views
Nov 9, 2023
YouTube
Pharma News & Analysis
See more videos
More like this
Feedback